Richard A. Young's most recent trade in Syros Pharmaceuticals Inc. was a trade of 2,667 Restricted Stock Units done . Disclosure was reported to the exchange on Sept. 16, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Syros Pharmaceuticals Inc. | Richard A. Young | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2024 | 2,667 | 2,667 | - | - | Restricted Stock Units | |
| Syros Pharmaceuticals Inc. | Richard A. Young | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2024 | 2,667 | 10,667 (0%) | 0% | - | Common Stock | |
| Syros Pharmaceuticals Inc. | Richard A. Young | Director | Sale of securities on an exchange or to another person at price $ 5.12 per share. | 28 Jun 2024 | 34,837 | 8,000 (0%) | 0% | 5.1 | 178,365 | Common Stock |
| Omega Therapeutics Inc | Richard A. Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Syros Pharmaceuticals Inc. | Richard A. Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | |
| Syros Pharmaceuticals Inc. | Richard A. Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 4,000 | 42,837 (0%) | 0% | 0 | Common Stock | |
| Omega Therapeutics Inc | Richard A. Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 18,118 | 18,118 | - | - | Stock Option (Right to Buy) | |
| Omega Therapeutics Inc | Richard A. Young | Director | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 02 Jun 2023 | 5,000 | 739,118 | - | 8 | 40,000 | Common Stock |
| Syros Pharmaceuticals Inc. | Richard A. Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | |
| Syros Pharmaceuticals Inc. | Richard A. Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 4,000 | 36,171 (0%) | 0% | 0 | Common Stock | |
| Omega Therapeutics Inc | Richard A. Young | Director | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 01 May 2023 | 5,000 | 744,118 | - | 8 | 40,000 | Common Stock |
| Omega Therapeutics Inc | Richard A. Young | Director | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 06 Apr 2023 | 5,000 | 749,118 | - | 8 | 40,000 | Common Stock |
| Omega Therapeutics Inc | Richard A. Young | Director | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 17 Mar 2023 | 10,000 | 754,118 | - | 8 | 80,000 | Common Stock |
| Omega Therapeutics Inc | Richard A. Young | Director | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 10 Jan 2023 | 20,000 | 764,118 | - | 8 | 160,000 | Common Stock |
| Syros Pharmaceuticals Inc. | Richard A. Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2022 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Syros Pharmaceuticals Inc. | Richard A. Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2022 | 8,000 | 8,000 | - | - | Restricted Stock Units | |
| Omega Therapeutics Inc | Richard A. Young | Director | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 14 Sep 2022 | 10,000 | 784,118 | - | 8 | 80,000 | Common Stock |
| Omega Therapeutics Inc | Richard A. Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 18,118 | 18,118 | - | - | Option (Right to Buy) | |
| Syros Pharmaceuticals Inc. | Richard A. Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 17,500 | 17,500 | - | - | Stock Option (right to buy) | |
| Syros Pharmaceuticals Inc. | Richard A. Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 17,500 | 17,500 | - | - | Stock Option (right to buy) | |
| Syros Pharmaceuticals Inc. | Richard A. Young | Director | Sale of securities on an exchange or to another person at price $ 12.05 per share. | 16 Feb 2021 | 3,750 | 321,711 (0%) | 0% | 12.1 | 45,188 | Common Stock |
| Syros Pharmaceuticals Inc. | Richard A. Young | Director | Sale of securities on an exchange or to another person at price $ 13.04 per share. | 08 Feb 2021 | 3,750 | 325,461 (0%) | 0% | 13.0 | 48,900 | Common Stock |
| Syros Pharmaceuticals Inc. | Richard A. Young | Director | Sale of securities on an exchange or to another person at price $ 8.75 per share. | 16 Nov 2020 | 5,357 | 339,211 (0%) | 0% | 8.8 | 46,874 | Common Stock |
| Syros Pharmaceuticals Inc. | Richard A. Young | Director | Sale of securities on an exchange or to another person at price $ 8.98 per share. | 16 Nov 2020 | 633 | 344,568 (0%) | 0% | 9.0 | 5,684 | Common Stock |
| Syros Pharmaceuticals Inc. | Richard A. Young | Director | Sale of securities on an exchange or to another person at price $ 8.75 per share. | 19 Oct 2020 | 5,673 | 335,201 (0%) | 0% | 8.8 | 49,639 | Common Stock |
| Syros Pharmaceuticals Inc. | Richard A. Young | Director | Sale of securities on an exchange or to another person at price $ 8.75 per share. | 15 Oct 2020 | 317 | 340,874 (0%) | 0% | 8.8 | 2,774 | Common Stock |
| Syros Pharmaceuticals Inc. | Richard A. Young | Director | Sale of securities on an exchange or to another person at price $ 10.39 per share. | 15 Sep 2020 | 5,990 | 341,191 (0%) | 0% | 10.4 | 62,236 | Common Stock |
| Syros Pharmaceuticals Inc. | Richard A. Young | Director | Sale of securities on an exchange or to another person at price $ 12.59 per share. | 17 Aug 2020 | 5,990 | 347,181 (0%) | 0% | 12.6 | 75,414 | Common Stock |
| Syros Pharmaceuticals Inc. | Richard A. Young | Director | Sale of securities on an exchange or to another person at price $ 11.85 per share. | 15 Jul 2020 | 5,990 | 353,171 (0%) | 0% | 11.9 | 70,982 | Common Stock |